Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02421952 · ClinicalTrials.gov registry record
Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children
A clinical trial of Postoperative Nausea and Vomiting, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 208
- Enrollment target
- 1
- Study location
NCT02421952: Completed study of Postoperative Nausea and Vomiting, sponsored by Baylor College of Medicine.
NCT02421952 is a study of Postoperative Nausea and Vomiting that has completed, run by Baylor College of Medicine. The registered enrollment target is 208 participants, below the 413-participant average among 10 other Postoperative Nausea and Vomiting trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02421952, a study of Postoperative Nausea and Vomiting, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
Pediatric research in the management of nausea has been limited by the absence of a reliable method to quantify the intensity of this subjective symptom. In adults, the visual analog scale (VAS) is an accurate tool, but this has not been shown to be reliable in young children. By default the most common objective outcome measure used in pediatric studies has been the incidence and number of emetic episodes. This measure, however, correlates poorly with the somatic subjective symptom of nausea.
Primary Outcome
To measure pain and nausea, subjects completed the VAS and two pictorial scales (Faces Pain Scale-Revised for pain and BARF for nausea). The VAS uses a horizontal 10cm line with the extremes of "no pain at all" and "worst pain imaginable". The subject marks on the line their pain rating. Higher points indicate more severe or intense pain. FACES scale has 6 faces with assigned scores ranging from 0 to 10 with a score difference of 2 between each face (a higher score indicates more pain). The BARF
Conditions Studied
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2013-04 |
| Est. Completion | 2018-09-07 |
What the finished NCT02421952 record still lists
NCT02421952 is an observational study that tracks outcomes without assigning an intervention. The registered 208 participants enrollment target is mid-sized for trials with a published cap, below the 413-participant average among 10 other Postoperative Nausea and Vomiting trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Postoperative Nausea and Vomiting appearing as the primary indexed condition, and to 0 interventions.
NCT02421952 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02421952 about?
NCT02421952 is a clinical study titled "Clinical Use of Baxter Animated Retching Faces (BARF) Scale in Children". Pediatric research in the management of nausea has been limited by the absence of a reliable method to quantify the intensity of this subjective symptom. In adults, the visual analog scale (VAS) is an accurate tool, but this has not been shown to be reliable in young children. By default the most co...
What is the current status of trial NCT02421952?
This trial is currently completed. The enrollment target is 208 participants. The study started on 2013-04. Estimated completion is 2018-09-07.
What conditions does trial NCT02421952 study?
This clinical trial studies the following conditions: Postoperative Nausea and Vomiting.
Who is sponsoring clinical trial NCT02421952?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02421952 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Nausea and Vomiting
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02421952's enrollment target sits among peer trials
208 5th of 10 higher than 6 of 10 other Postoperative Nausea and Vomiting trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Nausea and Vomiting trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
RECRUITING · NA
-
Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery
RECRUITING · Phase 2
-
A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population
RECRUITING · Phase 3
-
Costs of Postoperative Nausea and Vomiting in Ambulatory Surgery Patients
COMPLETED
-
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
COMPLETED · Phase 3
-
Study of APD421 as PONV Treatment (Prior Prophylaxis)
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465774 · 208 participants
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
- NCT03803332 · 208 participants · NA
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
- NCT04732065 · 208 participants · Phase 1
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
- NCT05293756 · 208 participants · NA
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia